Increased antibodies to capsular polysaccharide (CPS) and pilus island (PI) during recovery suggests that group B Streptococcus (GBS) bacteremia in adults is potentially vaccine preventable, a recent study showed. Prospective surveillance from 7 hospitals in Houston, TX, identified 102 nonpregnant adults (59% male; 44% white, 30% black, 25% Hispanic) with GBS bacteremia. All patients had ≥1 condition that enhanced risk for invasive GBS disease. Researchers found:
- 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis.
- CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods.
- Pili (89%) were most often PI-2a.
- CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI.
- All GBS expressed CPS or PI; 79% expressed both.
Edwards MS, Rench MA, Rinaudo CD, et al. Immune responses to invasive group B Streptococcal disease in adults. Emerg Infect Dis. 2016;22(11). doi:10.3201/eid2211.160914.
This Week's Must Reads
Must Reads in Emerging Infections
Meningococcal Disease Outbreaks in the US, Clin Infect Dis; ePub 2018 Jun 30; Mbaeyi, et al
Severe Respiratory Illness Linked to Rhinovirus, Clin Infect Dis; ePub 2017 Nov 23; Prill, et al
Seroreactivity to C6 Peptide in B. Miyamotoi Infections, Clin Infect Dis; ePub 2017 Nov 15; Molloy, et al
Regional Strategies to Limit Spread of CRE , Am J Infect Control; 2017 Nov 1; Gohil, et al